| Full text | |
| Author(s): |
Mendonca, Berenice B.
;
Batista, Rafael Loch
;
Domenice, Sorahia
;
Costa, Elaine M. F.
;
Arnhold, Ivo J. P.
;
Russell, David W.
;
Wilson, Jean D.
Total Authors: 7
|
| Document type: | Review article |
| Source: | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY; v. 163, p. 206-211, OCT 2016. |
| Web of Science Citations: | 21 |
| Abstract | |
Dihydrotestosterone is a potent androgen metabolite formed from testosterone by action of 5 alpha-reductase isoenzymes. Mutations in the type 2 isoenzyme cause a disorder of 46,XY sex development, termed 5a-reductase type 2 deficiency and that was described forty years ago. Many mutations in the encoding gene have been reported in different ethnic groups. In affected 46,XY individuals, female external genitalia are common, but Mullerian ducts regress, and the internal urogenital tract is male. Most affected males are raised as females, but virilization occurs at puberty, and male social sex develops thereafter with high frequency. Fertility can be achieved in some affected males with assisted reproduction techniques, and adults with male social sex report a more satisfactory sex life and quality of life as compared to affected individuals with female social sex. (C) 2016 Elsevier Ltd. All rights reserved. (AU) | |
| FAPESP's process: | 13/02162-8 - Molecular pathogenesis and characterization of monogenic developmental diseases: a route to translational medicine |
| Grantee: | Berenice Bilharinho de Mendonça |
| Support Opportunities: | Research Projects - Thematic Grants |